Antibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 21379-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- CHRNA7 antibody
- Antibody type
- Polyclonal
- Description
- CHRNA7 antibody (Cat. #21379-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, rat, mouse and has been validated for the following applications: FC, IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references The Spinal α7-Nicotinic Acetylcholine Receptor Contributes to the Maintenance of Cancer-Induced Bone Pain.
Autophagy is Involved in Neuroprotective Effect of Alpha7 Nicotinic Acetylcholine Receptor on Ischemic Stroke.
Differential Expression of Nicotine Acetylcholine Receptors Associates with Human Breast Cancer and Mediates Antitumor Activity of αO-Conotoxin GeXIVA.
Alpha7 nAChR Expression Is Correlated with Arthritis Development and Inhibited by Sinomenine in Adjuvant-Induced Arthritic Rats.
Identification of nicotinic acetylcholine receptor subunits in different lung cancer cell lines and the inhibitory effect of alpha-conotoxin TxID on lung cancer cell growth.
Cervical Cancer Correlates with the Differential Expression of Nicotinic Acetylcholine Receptors and Reveals Therapeutic Targets.
Activation of α7 nicotinic acetylcholine receptor alleviates Aβ1-42-induced neurotoxicity via downregulation of p38 and JNK MAPK signaling pathways.
Yang T, Zhou Y, Zhang W, Zhang L, Chen S, Chen C, Gao F, Yang H, Manyande A, Wang J, Tian Y, Tian X
Journal of pain research 2021;14:441-452
Journal of pain research 2021;14:441-452
Autophagy is Involved in Neuroprotective Effect of Alpha7 Nicotinic Acetylcholine Receptor on Ischemic Stroke.
Xu ZQ, Zhang JJ, Kong N, Zhang GY, Ke P, Han T, Su DF, Liu C
Frontiers in pharmacology 2021;12:676589
Frontiers in pharmacology 2021;12:676589
Differential Expression of Nicotine Acetylcholine Receptors Associates with Human Breast Cancer and Mediates Antitumor Activity of αO-Conotoxin GeXIVA.
Sun Z, Zhangsun M, Dong S, Liu Y, Qian J, Zhangsun D, Luo S
Marine drugs 2020 Jan 17;18(1)
Marine drugs 2020 Jan 17;18(1)
Alpha7 nAChR Expression Is Correlated with Arthritis Development and Inhibited by Sinomenine in Adjuvant-Induced Arthritic Rats.
Peng C, Shi QP, Liu JY, Lv YJ, Li J, Yi L, Bai SS, Liu L, Wang PX, Zhou H, Huang KE, Dong Y
Evidence-based complementary and alternative medicine : eCAM 2019;2019:3759304
Evidence-based complementary and alternative medicine : eCAM 2019;2019:3759304
Identification of nicotinic acetylcholine receptor subunits in different lung cancer cell lines and the inhibitory effect of alpha-conotoxin TxID on lung cancer cell growth.
Qian J, Liu YQ, Sun ZH, Zhangsun DT, Luo SL
European journal of pharmacology 2019 Dec 15;865:172674
European journal of pharmacology 2019 Dec 15;865:172674
Cervical Cancer Correlates with the Differential Expression of Nicotinic Acetylcholine Receptors and Reveals Therapeutic Targets.
Liu Y, Qian J, Sun Z, Zhangsun D, Luo S
Marine drugs 2019 Apr 28;17(5)
Marine drugs 2019 Apr 28;17(5)
Activation of α7 nicotinic acetylcholine receptor alleviates Aβ1-42-induced neurotoxicity via downregulation of p38 and JNK MAPK signaling pathways.
Chang KW, Zong HF, Ma KG, Zhai WY, Yang WN, Hu XD, Xu JH, Chen XL, Ji SF, Qian YH
Neurochemistry international 2018 Nov;120:238-250
Neurochemistry international 2018 Nov;120:238-250
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The CHRNA7 antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human CHRNA7. This antibody recognizes human, mouse, rat antigen. The CHRNA7 antibody has been validated for the following applications: ELISA, WB analysis.